CHICAGO -- The choice between furosemide and torsemide didn't matter for longer-term clinical outcomes of hospitalized heart failure patients, according to the comparative effectiveness trial ...

Dr. Hershberger answers the question: 'Diuretics To Treat Heart Failure?' — -- Question: What are the commonly used diuretics in the treatment of heart failure? Answer: The most commonly used ...

There exists a unique and clinically relevant time course of urinary drug delivery for a loop diuretic at which the natriuretic response is optimized. This rate of drug delivery resides on the steep ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window GRAPEVINE, Texas ...

Loop diuretics, and in particular furosemide, are the most effective agents for the management of signs and symptoms of fluid overload in patients with heart failure (HF). Indeed, through their ...

LISBON, Portugal—The use of intravenous furosemide plus the thiazide-like diuretic metolazone resulted in significantly better natriuresis, as well as greater increase in urine volume and a larger ...

In an observational study, furosemide doses of 250 to 500 mg and spironolactone doses of 50 to 100 mg were independently associated with approximately 14% and 20% increased odds of hyponatremia, ...

CHICAGO, IL—The choice of loop diuretic doesn’t make a difference in how patients hospitalized for heart failure fare, at least when it comes to their risk of dying or of being readmitted, the ...

Furosemide is the most widely prescribed loop diuretic in the setting of systolic heart failure (HF), yet torsemide has been shown to have less inter- and intra-individual variation in bioavailability ...

Drug therapy for patients with stable heart failure can be simplified by stopping diuretics, according to late-breaking results from the ReBIC-1 trial presented today at Heart Failure 2019, a ...

BURLINGTON, Mass., Oct. 8, 2025 /PRNewswire/ -- SQ Innovation, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its drug-device combination Lasix ® ONYU (furosemide ...